Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis

Molecular Neurobiology

Volumn 53, Issue 1, 2016, Pages 163-170

  Wei, XiangTai ^a   Chen, Duo ^a   Lv, Tao ^a   Li, Gang ^a   Qu, ShengTao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Diagnosis; Glioma; Meta analysis; MicroRNA 125b; Serum

Indexed keywords

MICRORNA 125B; MICRORNA; MIRN125 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLIOMA; HUMAN; INFORMED CONSENT; MALE; MULTICENTER STUDY (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; META ANALYSIS; MIDDLE AGED; PROGNOSIS;

ADULT; BIOMARKERS, TUMOR; FEMALE; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84953360937     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8993-1     Document Type: Article

References (29)

1. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA: Cancer J Clin 49(1):33–64, 31
2. Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, Tse V, Kalani MY (2010) The many roles of microRNAs in brain tumor biology. Neurosurg Focus 28(1):E3. doi:10.3171/2009.10.FOCUS09207
3. Gladson CL, Prayson RA, Liu WM (2010) The pathobiology of glioma tumors. Annu Rev Pathol 5:33–50. doi:10.1146/annurev-pathol-121808-102109
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. doi:10.1007/s00401-007-0243-4
5. Ilhan-Mutlu A, Wagner L, Preusser M (2013) Circulating biomarkers of CNS tumors: an update. Biomark Med 7(2):267–285. doi:10.2217/bmm.13.12
6. Mann DV, Edwards R, Ho S, Lau WY, Glazer G (2000) Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 26(5):474–479. doi:10.1053/ejso.1999.0925
7. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL (2008) Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol: Off J Am Soc Clin Oncol 26(1):96–105. doi:10.1200/JCO.2007.12.1053
8. Kersten MJ, Evers LM, Dellemijn PL, van den Berg H, Portegies P, Hintzen RQ, van Lier RA, von dem Borne AE, van Oers RH (1996) Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 87(5):1985–1989
9. Schroers R, Baraniskin A, Heute C, Kuhnhenn J, Alekseyev A, Schmiegel W, Schlegel U, Pels HJ (2010) Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas. Eur J Haematol 85(3):236–242. doi:10.1111/j.1600-0609.2010.01475.x
10. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853–858. doi:10.1126/science.1064921
11. Jovanovic M, Hengartner MO (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25(46):6176–6187. doi:10.1038/sj.onc.1209912
12. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257–2261. doi:10.1073/pnas.0510565103
13. Hwang HW, Mendell JT (2007) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 96(Suppl):R40–R44
14. Mar-Aguilar F, Mendoza-Ramirez JA, Malagon-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodriguez-Padilla C, Resendez-Perez D (2013) Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis Markers 34(3):163–169. doi:10.3233/dma-120957
15. Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, Araiza-Chavez J, Trevino V, Rodriguez-Padilla C, Resendez-Perez D (2013) Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia-Pacific J Clin Oncol 9(1):53–59. doi:10.1111/j.1743-7563.2012.01548.x
16. Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E (2012) MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118(13):3426–3432. doi:10.1002/cncr.26587
17. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. International journal of cancer Journal international du cancer 125(2):345–352. doi:10.1002/ijc.24390
18. Zhang Y, Jiang L (2014) CRP 1059 G/C and 1846G/A polymorphisms and cancer risk: A meta-analysis of 26,634 subjects. Clin Res Hepatol Gastroenterol. doi:10.1016/j.clinre.2014.04.002
19. Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG (2005) Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21(6):1469–1477. doi:10.1111/j.1460-9568.2005.03978.x
20. Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H, Hu C (2013) Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol 139(2):223–229. doi:10.1007/s00432-012-1315-y
21. Ma Y, Tian Z, Zhang W (2012) Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol 138(12):2045–2050. doi:10.1007/s00432-012-1285-0
22. (2002) International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics 182:17–23
23. Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zollner H, Schmiegel W, Hahn S, Schroers R (2012) Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro-Oncology 14(1):29–33. doi:10.1093/neuonc/nor169
24. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31. doi:10.1186/1471-2288-6-31
25. Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374(9690):609–619. doi:10.1016/S0140-6736(09)60879-5
26. Deeks JJ (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323(7305):157–162
27. Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, Martinez A, Balague O, Garcia-Foncillas J (2008) Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 18(8):823–833. doi:10.1038/cr.2008.81
28. Walter SD (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21(9):1237–1256. doi:10.1002/sim.1099
29. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033. doi:10.1158/0008-5472.CAN-05-0137